Disease-associated mutations in nonmuscle myosin heavy chains II-B and II-C alter their enzymatic and motile activities, providing mechanistic insight into the resulting phenotypes.
No takes yet. Share an insight, caveat, or question.
Altered myosin function from these mutations offers mechanistic clues; leaves open relevance to human disease phenotypes.
Kim et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: